Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Implications of Facebook's Page Commenting Changes

  • Broadcast in Business
  • 0 comments
Pharmaguy

Pharmaguy

×  

Follow This Show

If you liked this show, you should follow Pharmaguy.
h:755
s:1772005
archived

Interview of Matt Snodgrass, Social Media Director at WCG, about Facebook's planned changes to its "whitelisting" policy and its implications for pharmaceutical marketers.

Comments

 comments